Lisinopril Cost in Indiana 2026: Cash Prices, Medicaid, Insurance, and Discount Programs

What Lisinopril Actually Costs in Indiana Right Now

Generic lisinopril runs about $8 per month cash-pay at Indiana retail pharmacies in 2026. That figure is the average across major chains such as CVS, Walgreens, Walmart, and Kroger for a standard 30-day supply of 10 mg or 20 mg tablets. The manufacturer list price sits near $50 per month, but virtually no patient pays list price for this generic drug.

Lisinopril belongs to the ACE inhibitor drug class. It has been available as a generic since the early 2000s and is one of the most prescribed antihypertensives in the United States, with tens of millions of prescriptions dispensed annually [1]. Because generic competition is intense, retail pricing in Indiana has stayed low for over a decade.

The FDA first approved lisinopril under the brand names Prinivil and Zestril. Both brands remain on the market but are rarely prescribed because the generic is therapeutically identical and far cheaper [2]. At Walmart's $4 generic program, a 30-day supply of lisinopril 10 mg or 20 mg may cost as little as $4, making it one of the most affordable prescription drugs available anywhere in Indiana.

Prices vary modestly by pharmacy. A 90-day supply at Costco or Sam's Club pharmacy often runs $10 to $15 total, which works out to roughly $4 to $5 per month. Independent pharmacies in smaller Indiana cities like Terre Haute or Muncie may charge slightly more, but rarely above $15 per month without a discount card.

The ALLHAT trial (N=33,357), published in JAMA 2002, remains the landmark evidence that placed lisinopril alongside chlorthalidone as a first-line hypertension agent [3]. ALLHAT compared chlorthalidone, amlodipine, and lisinopril head-to-head and found no significant difference in the primary outcome of combined fatal coronary heart disease or nonfatal MI. That trial's findings directly influenced U.S. guideline adoption of ACE inhibitors as first-line therapy, which in turn drove the massive generic manufacturing volume that keeps Indiana cash prices so low today [3].

The 2017 ACC/AHA guideline on high blood pressure defines Stage 1 hypertension as systolic 130 to 139 mmHg or diastolic 80 to 89 mmHg, and ACE inhibitors including lisinopril are listed as one of four preferred first-line classes alongside thiazide diuretics, calcium channel blockers, and ARBs [4]. That guideline language reads: "Thiazide diuretics, CCBs, ACEIs, or ARBs are recommended as first-line therapy for most hypertensive adults" [4]. The breadth of that recommendation is precisely why generic lisinopril manufacturing scale is so large.

Does Indiana Medicaid Cover Lisinopril?

Indiana Medicaid does not broadly cover lisinopril for hypertension alone as a stand-alone indication in 2026. Coverage is available for Medicaid-enrolled patients whose lisinopril prescription is tied to type 2 diabetes management, diabetic nephropathy, or approved heart failure protocols.

Indiana's Medicaid program (Healthy Indiana Plan, or HIP 2.0) uses a preferred drug list (PDL) that determines which drugs are covered without prior authorization. Generic lisinopril does appear on the Indiana PDL for diabetic nephropathy, consistent with American Diabetes Association (ADA) standards recommending ACE inhibitors as first-line agents for patients with diabetes and hypertension or albuminuria [5]. The ADA's Standards of Medical Care in Diabetes state: "In patients with diabetes and hypertension, an ACE inhibitor or ARB is recommended for those with moderately or severely elevated urinary albumin-to-creatinine ratio" [5].

If your diagnosis code on the prescription is limited to essential hypertension (ICD-10 I10) without a comorbid diabetes or heart failure diagnosis, Indiana Medicaid may not pay. Patients in this situation should ask their prescriber whether adding the appropriate secondary diagnosis to the claim could trigger coverage.

Indiana's Medicaid managed care organizations (MCOs), including Anthem, MDwise, and Managed Health Services, each maintain their own formularies within state PDL rules [6]. Calling your specific MCO's member services line before filling is the fastest way to confirm current formulary status, since formularies update quarterly.

For Medicaid patients denied coverage, the $4 to $8 cash-pay price at Walmart or Kroger is often cheaper than the plan's co-pay structure anyway. This is not unique to Indiana: a 2019 JAMA Internal Medicine analysis found that for 23% of filled generic prescriptions, the GoodRx cash price was lower than the patient's insurance co-pay [7].

Which Indiana Insurance Plans Cover Lisinopril?

Most commercial health insurance plans in Indiana cover generic lisinopril, typically on Tier 1 of the formulary, meaning the lowest co-pay tier. Co-pays for Tier 1 generics across Indiana's major insurers generally range from $0 to $10 per 30-day fill in 2026.

Anthem Blue Cross Blue Shield Indiana, the state's largest commercial insurer, places generic lisinopril on its Tier 1 preferred generic tier across most plan types, including employer-sponsored PPOs, marketplace ACA plans, and Medicare Advantage products [8]. Cigna, UnitedHealthcare, and Humana Indiana plans follow similar formulary structures for this drug class.

Medicare Part D plans in Indiana universally cover generic lisinopril. Under the Inflation Reduction Act's 2025 redesign of Part D, the out-of-pocket cap of $2,000 per year applies, and Tier 1 generic co-pays on most Indiana Part D plans are $0 to $5 per fill [9]. The Centers for Medicare and Medicaid Services confirmed that ACE inhibitors are protected-class drugs for certain covered uses, reducing the likelihood of mid-year formulary removal [9].

Employer self-funded plans in Indiana are not required to follow state insurance mandates but almost universally cover generic antihypertensives because the clinical and cost evidence is so strong. If your employer plan denies lisinopril, a pharmacist-initiated substitution to another ACE inhibitor like enalapril is unlikely to resolve the issue since both are in the same class. Ask your prescriber to file a medical necessity appeal citing the ACC/AHA 2017 guidelines [4].

Short-term health plans sold in Indiana, which were expanded under federal rules in 2018, often have more limited formularies. Some explicitly exclude coverage for pre-existing conditions including hypertension for up to 364 days. Patients on short-term plans should verify formulary status directly with the insurer and budget for cash-pay pricing.

Is Compounded Lisinopril Legal in Indiana?

Compounded lisinopril is legal in Indiana when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. Indiana does not have a blanket prohibition on compounding ACE inhibitors.

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies may prepare lisinopril formulations for individual patients when a specific clinical need exists, such as a requirement for a dose form not commercially available, an allergy to a commercial tablet excipient, or a documented need for a different concentration [10]. The FDA's guidance on 503A compounding notes that compounded drugs must not be "essentially a copy" of a commercially available product without an identified clinical difference [10].

In Indiana, compounding pharmacies are licensed and inspected by the Indiana State Board of Pharmacy. The board's rules require compliance with USP Chapter 795 standards for non-sterile compounding, which covers oral solutions, suspensions, and alternative-dose tablets [11]. Patients who need a liquid formulation of lisinopril, common in pediatric or dysphagia situations, may legally obtain a compounded oral suspension through a 503A pharmacy with a valid prescription.

Some telehealth platforms operating in Indiana offer compounded lisinopril programs at no cost to the patient as part of a broader cardiovascular risk management subscription. These arrangements are legal provided the prescriber is licensed in Indiana, the compounding pharmacy holds a valid 503A license, and the compounded preparation differs meaningfully from the commercially available tablet. The FDA's 503A framework explicitly allows this structure [10].

Cost for compounded lisinopril through these programs can be $0 per month after subscription fees. Patients considering this route should confirm the compounding pharmacy's National Association of Boards of Pharmacy (NABP) accreditation status, as NABP's PCAB accreditation signals compliance with quality standards [11].

Discount Programs and Savings Cards for Lisinopril in Indiana

Several legitimate programs can reduce your lisinopril cost in Indiana to under $5 per month or even to $0.

GoodRx is the most widely used discount program at Indiana pharmacies. A GoodRx coupon for generic lisinopril 10 mg, 30 tablets, shows prices as low as $4 at Kroger and $4 to $7 at CVS and Walgreens statewide as of early 2026. GoodRx is not insurance; it is a discount card that negotiates pricing through pharmacy benefit managers. You cannot use GoodRx simultaneously with insurance, but for a drug this cheap, cash plus GoodRx often beats an insurance co-pay [7].

RxSaver, Blink Health, and NeedyMeds offer comparable discount structures in Indiana with prices in the $4 to $9 range for a 30-day supply. All three programs are free to use and accepted at most Indiana pharmacies.

The Walmart $4 generic list includes lisinopril in select doses. Patients filling at any Indiana Walmart pharmacy can confirm current inclusion by asking the pharmacist directly, as the list updates periodically.

NeedyMeds maintains a database of patient assistance programs. Zestril's original manufacturer no longer offers a branded patient assistance program since generic dominance has made it commercially irrelevant, but NeedyMeds lists state programs including Indiana's Prescription Assistance Program (PAP) for low-income uninsured residents [12].

Indiana's FSSA (Family and Social Services Administration) administers several pharmaceutical assistance initiatives for residents who do not qualify for Medicaid but fall below 200% of the federal poverty level. Patients in that income bracket should contact FSSA at 1-800-403-0864 to assess eligibility before paying cash [6].

The Extra Help (Low Income Subsidy) program for Medicare Part D enrollees in Indiana reduces or eliminates Part D co-pays for qualifying low-income beneficiaries. For a Tier 1 generic like lisinopril, Extra Help recipients typically pay $0 to $1.35 per fill in 2026 [9].

Telehealth Prescribing of Lisinopril in Indiana

Telehealth prescribing of lisinopril is legal in Indiana as of 2026. A licensed Indiana prescriber, including physicians, nurse practitioners, and physician assistants with prescriptive authority, may evaluate a patient via synchronous audio-video telehealth and issue a valid lisinopril prescription without an in-person visit.

Indiana Code 25-1-9.5 governs telehealth practice in the state and does not require an initial in-person visit for non-controlled substance prescriptions. Lisinopril is a non-controlled substance, so no DEA-specific telehealth restrictions apply [13]. The Indiana Medical Licensing Board has confirmed that the standard of care for telehealth prescribing requires the same clinical assessment as an in-person visit, including review of blood pressure readings, current medications, renal function labs, and contraindications such as pregnancy or history of angioedema [13].

Patients using telehealth for lisinopril initiation should have a home blood pressure cuff and be prepared to share readings with the provider. Most Indiana telehealth platforms require at least two weeks of home readings before starting or adjusting an ACE inhibitor. Baseline serum creatinine and potassium levels are typically requested within 30 days of starting lisinopril, consistent with JNC 8 monitoring recommendations [14].

The major telehealth platforms operating in Indiana and prescribing lisinopril include national services like Teladoc, MDLive, and HealthRX, as well as Indiana Health-affiliated virtual care services. Prescription costs through telehealth platforms are the same as described above: cash-pay runs $4 to $8 per month, or $0 with applicable insurance or discount programs.

One important clinical note: lisinopril is absolutely contraindicated in pregnancy. The FDA's labeling for lisinopril carries a black-box warning stating that ACE inhibitors can cause fetal injury and death when used during pregnancy [2]. Any telehealth prescriber operating in Indiana must screen for pregnancy status before prescribing, and female patients of childbearing age should discuss contraception planning with their provider.

How Lisinopril Works and Why Dose Matters for Cost

Lisinopril inhibits angiotensin-converting enzyme, which prevents conversion of angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor; blocking its production lowers peripheral vascular resistance and reduces blood pressure. The drug also reduces aldosterone secretion, modestly decreasing sodium and water retention [1].

FDA-approved doses range from 5 mg per day for heart failure initiation up to 40 mg per day for hypertension or 80 mg per day for heart failure in select patients [2]. For hypertension, 10 mg once daily is a common starting dose, titrated to 20 to 40 mg based on response. In the ALLHAT trial, the target dose was 10 to 40 mg daily, and mean achieved dose at year one was approximately 22 mg [3].

Dose affects cost modestly. A 40 mg tablet is not always double the price of a 20 mg tablet at the pharmacy level. In many cases, Indiana pharmacies charge the same dispensing fee regardless of tablet strength, meaning a patient on 40 mg per day may pay the same $8 cash-pay as a patient on 10 mg. However, if pill splitting is clinically appropriate, a prescriber can write for 20 mg tablets with instructions to take two daily, potentially accessing the lowest-priced tier at a given pharmacy.

Renal dosing is required for patients with creatinine clearance below 30 mL/min. The FDA label recommends starting at 2.5 to 5 mg per day in this population [2]. These lower-dose tablets are equally inexpensive in Indiana, with 2.5 mg and 5 mg strengths falling in the same $4 to $8 price range.

Monitoring Requirements and How They Affect Total Cost

Lisinopril requires periodic laboratory monitoring that adds to the total treatment cost beyond just the pill price. Serum potassium and creatinine should be checked one to two weeks after initiation and then every three to six months in stable patients, per JNC 8 guidance [14].

Hyperkalemia is a clinically significant risk, particularly in patients with CKD, diabetes, or concurrent use of potassium-sparing diuretics or potassium supplements. A 2016 analysis in the Journal of the American Heart Association found that ACE inhibitor-associated hyperkalemia led to discontinuation in approximately 2.3% of treated patients in primary care settings [15]. Monitoring catches this early.

In Indiana, a basic metabolic panel (BMP) at a commercial lab runs $20 to $45 without insurance. Quest Diagnostics and LabCorp both operate patient service centers in Indianapolis, Fort Wayne, South Bend, and Evansville with self-pay pricing available online. Several Indiana federally qualified health centers (FQHCs) offer sliding-scale lab fees for uninsured or underinsured patients, which can reduce a monitoring BMP to $5 to $15.

Adding the cost of two BMPs per year ($40 to $90) to the drug cost ($48 to $96 per year at $4 to $8 per month) gives a realistic annual total treatment cost for an uninsured Indiana patient of roughly $90 to $190 per year. That figure compares favorably to untreated hypertension's downstream costs: the CDC estimates that hypertension costs the U.S. healthcare system $131 billion annually in direct medical costs [16].

Drug Interactions Indiana Patients Should Know

Lisinopril carries several interactions relevant to common Indiana prescribing patterns. Non-steroidal anti-inflammatory drugs (NSAIDs), including ibuprofen and naproxen, widely available over the counter in Indiana, can blunt lisinopril's antihypertensive effect and increase the risk of acute kidney injury [2]. Patients should avoid regular NSAID use while on lisinopril.

Potassium supplements and potassium-sparing diuretics (spironolactone, triamterene) increase hyperkalemia risk when combined with lisinopril. The FDA label recommends close monitoring when these combinations are used [2]. Aliskiren, a direct renin inhibitor, is contraindicated with lisinopril in patients with diabetes, per the FDA's 2012 safety communication [17].

Sacubitril/valsartan (Entresto), increasingly prescribed for heart failure with reduced ejection fraction, should not be started within 36 hours of the last lisinopril dose due to risk of angioedema [18]. This interaction is directly relevant to Indiana cardiology and primary care practices managing heart failure patients transitioning between therapies.

Lithium levels may increase with concomitant ACE inhibitor use, requiring monitoring in psychiatric patients on lithium who are also being treated for hypertension [2].

Summary of the Cheapest Legal Ways to Get Lisinopril in Indiana

The lowest-cost legal path for most Indiana patients involves one of three routes. First, cash-pay at Walmart pharmacy using the $4 generic program or a GoodRx coupon at Kroger. Second, through commercial insurance at a $0 to $5 Tier 1 co-pay. Third, through a telehealth platform's compounded lisinopril program at $0 per month if the clinical criteria for compounding are met.

Patients who are uninsured, between $134 to $150 per month in drug costs for multiple conditions, or who find their Medicaid plan has not covered lisinopril, should call the Indiana FSSA helpline at 1-800-403-0864 to screen for the state PAP before paying full cash price [6].

For Medicare beneficiaries, applying for Extra Help through the Social Security Administration can reduce Part D co-pays for lisinopril to $0 to $1.35 per fill at any Indiana Part D-participating pharmacy [9].

Indiana patients with diabetic nephropathy who are on Indiana Medicaid should confirm that the lisinopril claim is submitted with the appropriate ICD-10 code (N08 or E11.65) to trigger PDL coverage rather than being billed as a plain hypertension prescription [5].